147 related articles for article (PubMed ID: 34998574)
1. Corrigendum to "siRNA: Mechanism of action, challenges, and therapeutic approaches" [Eur. J. Pharmacol. 905 (2021) 174178].
Alshaer W; Zureigat H; Al Karaki A; Al-Kadash A; Gharaibeh L; Hatmal MM; Aljabali AAA; Awidi A
Eur J Pharmacol; 2022 Feb; 916():174741. PubMed ID: 34998574
[No Abstract] [Full Text] [Related]
2. Corrigendum to: "Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice": [Eur.J.Pharmacol.670(2011)441-447].
Tsai SJ; Chao CY; Yin MC
Eur J Pharmacol; 2018 Jan; 819():293. PubMed ID: 29325911
[No Abstract] [Full Text] [Related]
3. Corrigendum to "Flaccidoside II ameliorates collagen-induced arthritis in mice" [Eur. J. Pharmacol. 880 (2020) 173155].
Zhang GB; Jia ZJ; Zhang MH; Li YJ; Tian LY; Cheng J
Eur J Pharmacol; 2021 Apr; 897():173963. PubMed ID: 33674037
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Tumor suppression effects of myoepithelial cells on mice breast cancer" [Eur. J. Pharmacol. 765 (2015) 171-178].
Farhangi B; Latifpour M; Alizadeh AM; Khodayari H; Khodayari S; Khaniki M; Ghasempour S
Eur J Pharmacol; 2016 Jul; 782():119. PubMed ID: 27180042
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33].
Guo Y; Zhang L; Li F; Hu CP; Zhang Z
Eur J Pharmacol; 2016 Jul; 782():120. PubMed ID: 27180043
[No Abstract] [Full Text] [Related]
6. Corrigendum to "The prophylaxis and treatment potential of supplements for COVID-19" [Eur. J. Pharmacol. 887 (15 November 2020) 173530].
Sahebnasagh A; Saghafi F; Avan R; Khoshi A; Khataminia M; Safdari M; Habtemariam S; Ghaleno HR; Nabavi SM
Eur J Pharmacol; 2024 Jun; 972():176571. PubMed ID: 38614058
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Sulfur dioxide derivatives attenuates consolidation of contextual fear memory in mice" [Eur. J. Pharmacol. 914 2021 174658].
Wang X; Zhao Y; Shi X; Gong M; Hao Y; Fu Y; Velez de-la-Paz OI; Wang X; Du Y; Guo X; Song L; Meng L; Gao Y; Yin X; Wang S; Shi H; Shi Y
Eur J Pharmacol; 2022 Mar; 918():174794. PubMed ID: 35125204
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis" [Eur. J. Pharmacol. 779 (2016) 20-30 doi: 10.1016/j.ejphar.2016.02.067].
Huang SS; Chen DZ; Wu H; Chen RC; Du SJ; Dong JJ; Liang G; Xu LM; Wang XD; Yang YP; Yu ZP; Feng WK; Chen YP
Eur J Pharmacol; 2024 Aug; 977():176713. PubMed ID: 38849042
[No Abstract] [Full Text] [Related]
9. Corrigendum to "P2Y14 receptor in trigeminal ganglion contributes to neuropathic pain in mice" [Eur. J. Pharmacol. 931 (2022) 175211].
Lin J; Fang X; Liu F; Zhang Y; Li Y; Fang Z; Tang Q; Li C; Zhou C; Shen J
Eur J Pharmacol; 2022 Oct; 932():175266. PubMed ID: 36096845
[No Abstract] [Full Text] [Related]
10. Corrigendum to "ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin pathway" [Eur. J. Pharmacol. 865 (2019) 172787].
Li LY; Yang CC; Yang JF; Li HD; Zhang BY; Zhou H; Hu S; Wang K; Huang C; Meng XM; Zhou H; Zhang L; Li J; Xu T
Eur J Pharmacol; 2020 Feb; 869():172848. PubMed ID: 31843196
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Pretreatment with obestatin reduces the severity of ischemia/reperfusion-induced acute pancreatitis in rats" [Eur. J. Pharmacol. 760 (2015) 113-121].
Bukowczan J; Warzecha Z; Ceranowicz P; Kuśnierz-Cabala B; Tomaszewska R; Dembinski A
Eur J Pharmacol; 2019 Jan; 842():384-385. PubMed ID: 30554633
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus" [Eur. J. Pharmacol. 728 (5 April 2014) 128-134].
Patel BM; Raghunathan S; Porwal U
Eur J Pharmacol; 2023 Sep; 954():175900. PubMed ID: 37451940
[No Abstract] [Full Text] [Related]
13. Corrigendum to 'Dezocine attenuates the remifentanil-induced postoperative hyperalgesia by inhibition of phosphorylation of CaMKⅡα' [Eur J Pharmacol. 2020 Feb 15; 869: 172882].
Zhou J; Qi F; Hu Z; Zhang L; Li Z; Wang ZJ; Tang H; Chen Z
Eur J Pharmacol; 2021 Oct; 908():174359. PubMed ID: 34298417
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway" [Eur. J. Pharmacol. 873 (2020) 173007].
Yuan H; Duan S; Guan T; Yuan X; Lin J; Hou S; Lai X; Huang S; Du X; Chen S
Eur J Pharmacol; 2020 Aug; 880():173160. PubMed ID: 32460965
[No Abstract] [Full Text] [Related]
15. Corrigendum to "The effect of cinnamaldehyde on passive avoidance memory and hippocampal Akt, ERK and GSK-3β in mice" [Eur. J. Pharmacol. 859 (2019) 172530].
SoukhakLari R; Borhani-Haghighi A; Farsadrooh A; Moezi L; Pirsalami F; Kazerouni A; Safari A; Moosavi M
Eur J Pharmacol; 2020 Apr; 873():173013. PubMed ID: 32087858
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model" [Eur J Pharmacol. 718 (1-3) (2013) 105-13].
Chang G; Zhang P; Ye L; Lu K; Wang Y; Duan Q; Zheng A; Qin S; Zhang D
Eur J Pharmacol; 2020 Feb; 869():172876. PubMed ID: 31877280
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension" [Eur. J. Pharmacol. 943 (2023) 175558].
Abdulkareem AO; Tiwari P; Lone ZR; Iqbal H; Gupta S; Jha RK; Chanda D; Jagavelu K; Hanif K
Eur J Pharmacol; 2023 Jul; 950():175750. PubMed ID: 37147146
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Identifying chronic alcoholism drug disulfiram as a potent DJ-1 inhibitor for cancer therapeutics" [Eur. J. Pharmacol. 926 (2022) 175035].
Wu Q; Zhang M; Wen Y; He P; He Q; Yang B; Jiang L; Yuan M; Cao J
Eur J Pharmacol; 2023 Mar; 942():175527. PubMed ID: 36707375
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice" [Eur. J. Pharmacol. 666 (2011) 196-204].
Li JM; Zhang X; Wang X; Xie YC; Kong LD
Eur J Pharmacol; 2022 Feb; 916():174740. PubMed ID: 34996605
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells" [Eur. J. Pharmacol. 938 (2023) 175411].
Yang JF; Chang HH; Chen TM; Tsai WC; Huang WY; Lo CH; Lin CS; Shen PC; Chen Y
Eur J Pharmacol; 2023 Dec; 960():176183. PubMed ID: 37953156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
